MACKENZIE FINANCIAL CORP
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 919859
TORONTO ONTARIO, A6
Position in MRVI
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$17,847,182
-$2,217,200 QoQ
Shares Held
6,306,425
+2.2% QoQ
Ownership
2.44%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $416,722,148 across 43 Biotechnology names. MRVI ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,779,636 | $93,003,777 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,317 | $66,691,966 | |
| 3 | INCY |
Incyte Corp
|
549,633 | $51,731,457 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
96,709 | $43,184,436 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
441,444 | $24,937,171 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
345,683 | $23,551,382 | |
| 7 | MRVI |
Maravai Lifesciences Holdings, Inc.
This page
|
6,306,425 | $17,847,182 | |
| 8 | RPRX |
Royalty Pharma plc
|
170,882 | $8,197,209 |
All Filings in MRVI
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,847,182 | 6,306,425 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $20,064,382 | 6,173,656 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $17,418,893 | 6,069,301 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,627,015 | 6,069,301 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $13,511,104 | 6,113,622 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $33,695,802 | 6,182,716 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $52,879,953 | 6,363,412 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $41,962,189 | 5,860,641 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $43,491,459 | 5,016,316 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $33,858,102 | 5,169,176 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $49,308,410 | 4,930,841 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $44,081,577 | 3,546,386 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $35,551,243 | 2,537,562 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $30,353,813 | 2,121,161 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,301,213 | 50,968 | Shares | Sole | 2022-10-07 | |
| No filing history on record for this holder in this stock. | ||||||